KP Tissue Inc. (TSE:KPT – Get Free Report)’s share price passed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of C$12.17 and traded as high as C$12.43. KP Tissue shares last traded at C$12.35, with a volume of 26,968 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, TD lowered their target price on KP Tissue from C$14.00 to C$13.00 and set a “hold” rating on the stock in a research note on Wednesday, October 14th. Three investment analysts have rated the stock with a Hold rating. According to MarketBeat, KP Tissue presently has a consensus rating of “Hold” and a consensus price target of C$11.88.
Check Out Our Latest Report on KPT
KP Tissue Stock Down 1.2%
The firm has a market capitalization of C$122.89 million, a price-to-earnings ratio of 13.92, a P/E/G ratio of -0.88 and a beta of 0.47. The company’s 50 day moving average is C$12.15 and its 200 day moving average is C$11.96.
KP Tissue (TSE:KPT – Get Free Report) last issued its quarterly earnings data on Wednesday, November 11th. The company reported C$0.31 earnings per share for the quarter. On average, analysts expect that KP Tissue Inc. will post 0.44 EPS for the current year.
KP Tissue Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 15th were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 6.9%. The ex-dividend date was Tuesday, September 29th. KP Tissue’s payout ratio is 85.23%.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Featured Articles
- Five stocks we like better than KP Tissue
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
